Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 595 clinical trials
Circulating Tumor Cell Detection in Patients With Luminal A Breast Cancer

tumor cells may develop abnormalities 4-6 months earlier than conventional imaging examination, as long as circulating tumor cells of patients are abnormal, timely PET-CT examination will neither miss

EGFR
estrogen receptor
cancer
progesterone receptor
breast cancer
  • 3 views
  • 15 May, 2022
  • 2 locations
PSMA-PET and MRI for Detection of Recurrent Prostate Cancer After Radical Treatment

over-treatment of prostate cancer patients with biochemical relapse following radical treatment. The purpose of this prospective multi-center study is to standardize PSMA PET/CT and PET/MRI imaging

bone scan
metastasis
pet/ct scan
prostatectomy
recurrent prostate cancer
  • 22 views
  • 20 Jun, 2022
  • 3 locations
The Role of Vitamin D in Predicting Response to Neoadjuvant Therapy in Patients With Rectal Cancer

. Therefore, the importance of predicting patients with pathological complete response has increased. It has been reported that data obtained from PET-CT scans and clinical information such as tumor

  • 0 views
  • 02 May, 2021
  • 1 location
Amyloid and Glucose PET Imaging in Alzheimer and Vascular Cognitive Impairment Patients With Significant White Matter Disease (MITNEC C6)

. Repeat MR and PET/CT imaging and neuropsychological testing will be conducted at 24 months. The follow up assessments can also be completed at either year 1 or year 3 or Year 4 depending on the

cognitive impairment
amyloid
neuropsychological test
mental state examination
cognitive decline
  • 98 views
  • 12 May, 2022
  • 7 locations
Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging

Quantitative parameters obtained with dynamic whole body imaging using positron emission tomography (PET) can provide additional and complementary information to standard PET. Dynamic imaging allows for better understanding of the behavior of the radio-pharmaceutical because it can be followed over time. Thought to be difficult to perform with currently available …

fdg pet/ct
18f-fdg
positron emission tomography/computed tomography
pet/ct scan
pet scan
  • 3 views
  • 24 Feb, 2022
  • 1 location
Liquid Biopsy in Mature B-cell Tumors

The study aims at assessing whether cell free DNA genotyping can improve the accuracy of early prediction of cure in mature B-cell tumor patients and whether it represents an accessible source of tumor DNA for the sensitive identification of genetic biomarkers that refine the diagnostic workup, stratify prognosis and identify …

  • 0 views
  • 19 Sep, 2021
  • 1 location
SENTINEL LYMPH NODE BIOPSY AFTER NEOADJUVANT CHEMOTHERAPY (NEOSENTITURK)

Omitting axilary lymph node dissection (ALND) following SLNB with residual cancer in patients with locally advanced disease after neoadjuvan chemotherapy (NAC) is still controversial. In this study, the investigators evaluated factors affecting local recurrence and outcome in patients with locally advanced breast cancer (LABC), who underwent sentinel lymph node (SLN) …

Accepts healthy volunteers
  • 0 views
  • 25 Feb, 2022
  • 1 location
Longitudinal Imaging in Patients With Large Vessel Vasculitis to Predict Further Disease Course

Longitudinal imaging in patients with large vessel vasculitis to predict further disease course

positron emission tomography/computed tomography
vasculitis
  • 0 views
  • 14 Aug, 2021
  • 1 location
Dynamic Observational Study With PET of 68Ga-HER2-affibody in Anti-HER2 Treatment

Dynamic observationaL study with PET of 68Ga-HER2-affibody in anti-HER2 treatment

  • 0 views
  • 28 Apr, 2022
  • 1 location
Cell-free Tumor DNA as Minimal Residual Disease in Hodgkin Lymphoma Patients

Molecular analysis identifies residual disease by overcoming the sensitivity of imaging methods and therefore has the potential for integrating with therapy provided by FDG-PET alone. It is a well known fact that tumor DNA circulating in plasma (ctDNA) reflects the mutational profile of tumor cells and can be used to …

lymphoma
  • 0 views
  • 10 Mar, 2022
  • 1 location